Shravan Kumar Sriraman

840 citations
10 papers · 602 indexed · h-index 8
Topics
Nanoparticle-Based Drug Delivery (6 papers)Nanoplatforms for cancer theranostics (4 papers)RNA Interference and Gene Delivery (3 papers)

In The Last Decade

Shravan Kumar Sriraman

10 papers receiving 591 citations

Peers

Shravan Kumar Sriraman
Comparison fields: 5 of 84
  • Molecular Biology 321
  • Biomaterials 289
  • Biomedical Engineering 234
  • Oncology 94
  • Immunology 44
Replace Natalie D. Cummings with:
Natalie D. Cummings United States
Rohit Sukumar United States
Henrike Caysa Germany
Yongen Sun United States
P. Vasey United Kingdom
Lidia Mak Israel
Ilya Yakavets France
Dennis Huang United States
Jane-Guo Shiah United States
Bilyana M. Dicheva Netherlands
Shravan Kumar Sriraman relative to Natalie D. Cummings United States Natalie D. Cummings's profile →
Citations per field
00.5×1.5×1.8×
Natalie D. Cummings · 1×
Citations per year

Countries citing papers authored by Shravan Kumar Sriraman

Since Specialization
Citations

This map shows the geographic impact of Shravan Kumar Sriraman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shravan Kumar Sriraman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shravan Kumar Sriraman more than expected).

Fields of papers citing papers by Shravan Kumar Sriraman

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Shravan Kumar Sriraman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shravan Kumar Sriraman. The network helps show where Shravan Kumar Sriraman may publish in the future.

Co-authorship network of co-authors of Shravan Kumar Sriraman

This figure shows the co-authorship network connecting the top 25 collaborators of Shravan Kumar Sriraman. A scholar is included among the top collaborators of Shravan Kumar Sriraman based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Shravan Kumar Sriraman. Shravan Kumar Sriraman is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

10 of 10 papers shown
#WorkIndexed citations
1 1
2 15
3 84
4 59
5 18
6 44
7 50
8 1
9 245
10 85

About Shravan Kumar Sriraman

Shravan Kumar Sriraman is a scholar working on Biomaterials, Pharmacy and Reproductive Medicine, having authored 10 papers that have together received 602 indexed citations. Recurring topics across this work include Nanoparticle-Based Drug Delivery (6 papers), Nanoplatforms for cancer theranostics (4 papers) and RNA Interference and Gene Delivery (3 papers). The work is most often cited by research in Biomaterials (289 citations), Pharmaceutical Science (36 citations) and Biomedical Engineering (234 citations). Shravan Kumar Sriraman has collaborated with scholars based in United States, Saudi Arabia and Poland. Frequent co-authors include Vladimir P. Torchilin, Bhawani Aryasomayajula, Vladimir P. Torchilin, Can Sarısözen, Ed Luther, Swati Biswas, Gemma Navarro, Rupa R. Sawant, Yilin Zhang and Jiayi Pan. Their work appears in journals such as Biomaterials, Cancer Research and Oncogene.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026